LENZ THERAPEUTICS, INC. Earnings Per Share (Basic)
LENZ THERAPEUTICS, INC. (LENZ) reported Earnings Per Share (Basic) of -$1.02 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-11
- LENZ THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$1.02.
- LENZ THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$1.32.
- LENZ THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-12-31 was -$1.15.
- LENZ THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.59.
- LENZ THERAPEUTICS, INC. earnings per share, basic for fiscal 2025 was -$2.85.
- LENZ THERAPEUTICS, INC. earnings per share, basic for fiscal 2024 was -$2.34.
- LENZ THERAPEUTICS, INC. earnings per share, basic for fiscal 2023 was -$35.71.
- LENZ THERAPEUTICS, INC. earnings per share, basic for fiscal 2022 was -$1.84.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.02 10-Q · filed 2026-08-11 | -$2.34 10-Q · filed 2026-08-11 | -$3.49 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$4.12 derived: net income ÷ weighted average shares · filed 2026-08-11 | ||||
| 2026-03-31 | -$1.32 10-Q · filed 2026-05-11 | -$2.48 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$3.10 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$3.66 derived: net income ÷ weighted average shares · filed 2026-08-11 | ||||
| 2025-12-31 | -$1.15 derived: net income ÷ weighted average shares · filed 2026-03-24 | -$1.76 derived: net income ÷ weighted average shares · filed 2026-03-24 | -$2.31 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$2.85 10-K · filed 2026-03-24 | ||||
| 2025-09-30 | -$0.59 10-Q · filed 2025-11-05 | -$1.12 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$1.65 10-Q · filed 2025-11-05 | -$2.11 derived: net income ÷ weighted average shares · filed 2026-08-11 | ||||
| 2025-06-30 | -$0.53 10-Q · filed 2026-08-11 | -$1.06 10-Q · filed 2026-08-11 | -$1.52 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$1.90 derived: net income ÷ weighted average shares · filed 2026-08-11 | ||||
| 2025-03-31 | -$0.53 10-Q · filed 2026-05-11 | -$0.99 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$1.37 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$1.77 derived: net income ÷ weighted average shares · filed 2026-08-11 | ||||
| 2024-12-31 | -$0.46 derived: net income ÷ weighted average shares · filed 2026-03-24 | -$0.84 derived: net income ÷ weighted average shares · filed 2026-03-24 | -$1.24 derived: net income ÷ weighted average shares · filed 2026-03-24 | -$2.34 10-K · filed 2026-03-24 | ||||
| 2024-09-30 | -$0.38 10-Q · filed 2025-11-05 | -$0.78 derived: net income ÷ weighted average shares · filed 2025-11-05 | -$1.93 10-Q · filed 2025-11-05 | -$4.09 derived: net income ÷ weighted average shares · filed 2025-11-05 | ||||
| 2024-06-30 | -$0.40 10-Q · filed 2025-07-30 | -$1.77 10-Q · filed 2025-07-30 | -$4.70 derived: net income ÷ weighted average shares · filed 2025-11-05 | -$8.11 derived: net income ÷ weighted average shares · filed 2025-11-05 | ||||
| 2024-03-31 | -$3.53 10-Q · filed 2025-05-07 | -$12.07 derived: net income ÷ weighted average shares · filed 2025-11-05 | -$20.55 derived: net income ÷ weighted average shares · filed 2025-11-05 | -$27.90 derived: net income ÷ weighted average shares · filed 2025-11-05 | ||||
| 2023-12-31 | -$12.04 derived: net income ÷ weighted average shares · filed 2025-03-19 | -$21.67 derived: net income ÷ weighted average shares · filed 2025-03-19 | -$29.21 derived: net income ÷ weighted average shares · filed 2025-03-19 | -$35.71 10-K · filed 2025-03-19 | -$2.19 10-K · filed 2024-02-27 | |||
| 2023-09-30 | -$9.62 10-Q · filed 2024-11-06 | -$0.39 10-Q · filed 2023-11-13 | -$17.15 derived: net income ÷ weighted average shares · filed 2024-11-06 | -$23.66 10-Q · filed 2024-11-06 | -$1.79 10-Q · filed 2023-11-13 | -$4.60 derived: net income ÷ weighted average shares · filed 2024-11-06 | ||
| 2023-06-30 | -$7.53 10-Q · filed 2024-08-14 | -$0.97 10-Q · filed 2023-08-14 | -$14.02 10-Q · filed 2024-08-14 | -$1.40 10-Q · filed 2023-08-14 | -$2.62 derived: net income ÷ weighted average shares · filed 2024-11-06 | -$2.67 derived: net income ÷ weighted average shares · filed 2024-11-06 | ||
| 2023-03-31 | -$6.50 10-Q · filed 2024-05-08 | -$0.43 10-Q · filed 2023-05-11 | -$1.29 derived: net income ÷ weighted average shares · filed 2024-11-06 | -$1.65 derived: net income ÷ weighted average shares · filed 2024-11-06 | -$2.10 derived: net income ÷ weighted average shares · filed 2024-11-06 | |||
| 2022-12-31 | -$0.44 derived: net income ÷ weighted average shares · filed 2024-02-27 | -$0.89 derived: net income ÷ weighted average shares · filed 2024-02-27 | -$1.36 derived: net income ÷ weighted average shares · filed 2024-02-27 | -$1.84 10-K · filed 2024-02-27 | ||||
| 2022-09-30 | -$0.45 10-Q · filed 2023-11-13 | -$0.92 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$1.40 10-Q · filed 2023-11-13 | -$1.75 derived: net income ÷ weighted average shares · filed 2023-11-13 | ||||
| 2022-06-30 | -$0.48 10-Q · filed 2023-08-14 | -$0.95 10-Q · filed 2023-08-14 | -$1.31 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$1.59 derived: net income ÷ weighted average shares · filed 2023-11-13 | ||||
| 2022-03-31 | -$0.48 10-Q · filed 2023-05-11 | -$0.83 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$1.11 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$1.86 derived: net income ÷ weighted average shares · filed 2023-11-13 | ||||
| 2021-12-31 | -$0.35 derived: net income ÷ weighted average shares · filed 2023-03-20 | -$0.63 derived: net income ÷ weighted average shares · filed 2023-03-20 | -$1.37 derived: net income ÷ weighted average shares · filed 2023-03-20 | -$2.45 10-K · filed 2023-03-20 | ||||
| 2021-09-30 | -$0.28 10-Q · filed 2022-11-09 | -$1.11 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$2.51 10-Q · filed 2022-11-09 | |||||
| 2021-06-30 | -$3.45 10-Q · filed 2022-08-11 | -$8.45 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |